These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 26929370)

  • 21. The impact of HTLV-1 on the cellular genome.
    Cook L; Melamed A; Yaguchi H; Bangham CR
    Curr Opin Virol; 2017 Oct; 26():125-131. PubMed ID: 28822906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.
    Satou Y; Yasunaga J; Yoshida M; Matsuoka M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):720-5. PubMed ID: 16407133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
    Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
    J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo.
    Leclercq I; Mortreux F; Cavrois M; Leroy A; Gessain A; Wain-Hobson S; Wattel E
    J Virol; 2000 Mar; 74(5):2305-12. PubMed ID: 10666261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors.
    Harrod R
    Retrovirology; 2019 Sep; 16(1):25. PubMed ID: 31492165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of HBZ and Foxp3 mRNA in bronchoalveolar lavage cells taken from human T-lymphotropic virus type 1-associated lung disorder patients.
    Nakayama Y; Yamazato Y; Tamayose M; Atsumi E; Yara S; Higa F; Tateyama M; Fujita J
    Intern Med; 2013; 52(23):2599-609. PubMed ID: 24292748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes.
    Belrose G; Gross A; Olindo S; Lézin A; Dueymes M; Komla-Soukha I; Smadja D; Tanaka Y; Willems L; Mesnard JM; Peloponese JM; Césaire R
    Blood; 2011 Sep; 118(9):2483-91. PubMed ID: 21505188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription.
    Lemasson I; Lewis MR; Polakowski N; Hivin P; Cavanagh MH; Thébault S; Barbeau B; Nyborg JK; Mesnard JM
    J Virol; 2007 Feb; 81(4):1543-53. PubMed ID: 17151132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
    Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
    BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.
    Valeri VW; Hryniewicz A; Andresen V; Jones K; Fenizia C; Bialuk I; Chung HK; Fukumoto R; Parks RW; Ferrari MG; Nicot C; Cecchinato V; Ruscetti F; Franchini G
    Blood; 2010 Nov; 116(19):3809-17. PubMed ID: 20647569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adult T-cell leukemia induced by HTLV-1: before and after HBZ].
    Duc Dodon M; Mesnard JM; Barbeau B
    Med Sci (Paris); 2010 Apr; 26(4):391-6. PubMed ID: 20412744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the CTCF Binding Site in Human T-Cell Leukemia Virus-1 Pathogenesis.
    Joseph A; Cheng X; Harding J; Al-Saleem J; Green P; Veis D; Rauch D; Ratner L
    bioRxiv; 2024 May; ():. PubMed ID: 38853836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
    Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
    PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion.
    Silverman LR; Phipps AJ; Montgomery A; Ratner L; Lairmore MD
    J Virol; 2004 Apr; 78(8):3837-45. PubMed ID: 15047799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression.
    Yamamoto-Taguchi N; Satou Y; Miyazato P; Ohshima K; Nakagawa M; Katagiri K; Kinashi T; Matsuoka M
    PLoS Pathog; 2013 Sep; 9(9):e1003630. PubMed ID: 24068936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1.
    Panfil AR; Green PL; Yoder KE
    Front Cell Infect Microbiol; 2020; 10():580371. PubMed ID: 33425776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
    Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M
    Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling.
    Higuchi Y; Yasunaga JI; Mitagami Y; Tsukamoto H; Nakashima K; Ohshima K; Matsuoka M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13740-13749. PubMed ID: 32471947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach.
    Katsuya H; Islam S; Tan BJY; Ito J; Miyazato P; Matsuo M; Inada Y; Iwase SC; Uchiyama Y; Hata H; Sato T; Yagishita N; Araya N; Ueno T; Nosaka K; Tokunaga M; Yamagishi M; Watanabe T; Uchimaru K; Fujisawa JI; Utsunomiya A; Yamano Y; Satou Y
    Cell Rep; 2019 Oct; 29(3):724-735.e4. PubMed ID: 31618639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.